Blog
Summerschool Heidelberg funded by the Innovation Campus Heidelberg Mannheim Health & Life Sciences
06 September 2022
The Vagabond consortium is organizing their second Summerschool in Heidelberg that is funded by the Innovation Campus Heidelberg Mannheim Health & Life Sciences. We are happy to invite you to this 2 day (free of charge, including lunch) event on September 19th and 20th with multiple international experts in the field of pediatric oncology.
During this Summerschool we focus on the second step of the Proof of Concept (PoC) pipeline of pre-clinical drug development: in vitro validation. The scientific program includes talks on epi(genetic) and immunological research (multiple internationalVagabond PI’s/PhD students and PI’s from KiTZ/DKFZ). Please find the program here: https://vagabondnetwork.com/events/summerschool-heidelberg-september-2022/ . In addition you can join the interactive meet the speaker sessions and lunch breaks to interact with other international PhD fellows and PI’s working on similar topics in the field of pediatric oncology!
Due to limited space, tickets will be given out on a first come, first serve basis. So, register as soon as possible and before Sept 10th, because you don’t want to miss this exciting event!
Registration link: https://forms.gle/8r9kdkH2ZY5KJyez6
Cancelation policy = if you register and can’t come, please let us know as soon as possible by sending an e-mail to vagabond@prinsesmaximacentrum.nl In case of no show or last minute cancelations without a valid reason we will inform your Group Leader/PI.
The Innovation Campus Heidelberg Mannheim Health & Life Sciences thrives to promote research and innovation through synergy – by bridging world-leading life science and biomedical research institutions and by bringing together a highly diverse range of disciplines and a cluster of top researchers. Heidelberg University with its faculties of Medicine, Biosciences, and Engineering, the University Hospital Heidelberg (UKHD) and the University Hospital Mannheim, the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), the Max-Planck-Institute for Medical Research (MPIMR), and the Central Institute for Mental Health (ZI Mannheim) appoint top scientists, support junior researchers with cross-institutional programs and tap new potential, especially for the translation of research to patient care and the transfer into technological applications.